Phase II CoTikiS study of lusvertikimab has met primary and secondary endpoints, showing high rates of clinical and ...

OSE Immunotherapeutics Reports Full Phase 2 Induction Results for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ...

Investment group Eurazeo has made a $73.1 million investment in MPC OSE Offshore, a joint venture established by MPC Capital ...

First steel cut at Jiangsu Strongwind for the Lac Da Vang FSO marks key step towards the project’s mid-2026 delivery ...

A third of women infrequently, if ever, orgasm during sex. It’s a major inequity, one that Osé founder Lora Haddock was trying to solve when she came up against another: sexism in tech.

Since May 28, 2024, the New York Stock Exchange (“NYSE”) has been settling its trades on a T+1 basis, while the Oslo Stock Exchange (“OSE”) continues to settle its trades on a T+2 basis. As a result, ...

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics.

Tahoe Hall 1030 By Phone: (916) 278 - 2499 (BIZZ) By email: [email protected] Office hours : Monday, Wednesday, Thursday & Friday: 9 am - 12pm & 1:00 pm - 4pm Wednesday: 8 am - 12 pm & 1 pm - 3:15 pm ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Join us for free coffee and donuts at our kick-off event Crash the OSE during the first week each semester and check out the OSE Schedule of Events to see everything we have in store for you! Please ...

Investment and asset manager MPC Capital has completed a €70M (US$73M) equity raise for the first of a new class of offshore ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...